LIDOCAINE HYDROCHLORIDE VISCOUS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lidocaine Hydrochloride Viscous, and what generic alternatives are available?
Lidocaine Hydrochloride Viscous is a drug marketed by Actavis Mid Atlantic, Chartwell Molecular, Intl Medication, and Pai Holdings Pharm. and is included in four NDAs.
The generic ingredient in LIDOCAINE HYDROCHLORIDE VISCOUS is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride Viscous
A generic version of LIDOCAINE HYDROCHLORIDE VISCOUS was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIDOCAINE HYDROCHLORIDE VISCOUS?
- What are the global sales for LIDOCAINE HYDROCHLORIDE VISCOUS?
- What is Average Wholesale Price for LIDOCAINE HYDROCHLORIDE VISCOUS?
Summary for LIDOCAINE HYDROCHLORIDE VISCOUS
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 15 |
| Patent Applications: | 5 |
| DailyMed Link: | LIDOCAINE HYDROCHLORIDE VISCOUS at DailyMed |
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE VISCOUS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sawanpracharak hospital | N/A |
| Vrije Universiteit Brussel | Phase 4 |
| Walter Reed National Military Medical Center | Phase 2 |
Pharmacology for LIDOCAINE HYDROCHLORIDE VISCOUS
| Drug Class | Amide Local Anesthetic Antiarrhythmic |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE VISCOUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 086578-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pai Holdings Pharm | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 218138-001 | Feb 20, 2024 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Molecular | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 040708-001 | Feb 27, 2007 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Intl Medication | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 086389-001 | Feb 2, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
